The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 (VA - VHA VISN 9) awarded Roche Diagnostics Corporation a single-award indefinite delivery contract worth up to $815,294.66 to provide Roche reagents, diagnostic test kits, and associated laboratory equipment and supplies. This contract, which has a base period of one year and four option years through September 2025, will allow VISN 9 to efficiently order essential medical consumables and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to Roche Diagnostics Corporation to provide laboratory testing supplies and equipment. The IDV has a potential value of $6.5 million and period of performance through June 2027. Three delivery orders have been issued against the contract to date for a total of $246,135.04, $231,704.12, and $13,824 for reagents, supplies, and molecular testing systems...
The Department of Veterans Affairs (VA), Veterans Integrated Service Network 10, has awarded an Indefinite Delivery Contract (IDC) worth a ceiling value of $488,315.80 to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The contract, which does not utilize a small business set-aside, is for the provision of SARS-CoV-2 and Cytomegalovirus (CMV) test and control kits to support VA hospitals and medical facilities. Under a...
The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a single-award indefinite delivery contract (IDC) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics and laboratory instruments, to provide reagents, supplies, and consumables for Roche-manufactured Cobas 6800/8800 laboratory instruments. The $1,170,000 IDC has a 5-year ordering period ending on September 30, 2026. Under this IDC, the VA VHA has awarded multiple delivery orders to Roche...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) has awarded a Blanket Purchase Agreement (BPA) contract valued at $5,223,493.58 to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. Under this multiple award IDV, Roche will provide VENTANA histology reagents and supplies to support laboratory operations at VA medical centers in the VISN 1 network covering the northeastern U.S. The...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded Roche Diagnostics Corporation a blanket purchase agreement to provide laboratory diagnostic testing equipment and related supplies. The contract utilizes Roche's GSA Schedule 66-III for Critical Analyzers, Laboratory and has a total value of $406,632.45 over its December 18, 2021 to December 17, 2024 period of performance. Under the agreement and associated orders, Roche will...
The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The BPA, valued at up to $3,020,685.50, provides the VA's Veterans Integrated Service Network 16 with a streamlined vehicle to acquire HIV, hepatitis B (HBV), and hepatitis C (HCV) testing reagents and supplies on an as-needed basis over a 5-year period ending in October 2024. The...
The Department of Veterans Affairs (VA), through its Veterans Integrated Service Network 19 (VISN 19), has awarded a series of Blanket Purchase Agreement (BPA) call orders to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, and laboratory instruments. These contract awards, valued at over $11 million collectively, provide VISN 19 with comprehensive chemistry and immunochemistry laboratory services, including testing equipment, reagents, and...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a single award indefinite delivery contract to Roche Diagnostics Corporation with a potential value of $732,474.12 to provide testing supplies. Under this contract vehicle, two firm fixed price delivery orders have been issued to date. The first delivery order, valued at $82,852.16, requires Roche to supply testing materials to the Sioux Falls Health Care System from November 2023...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single award Indefinite Delivery Contract to Roche Diagnostics Corporation for COVID-19 diagnostic testing supplies. The contract established a potential value of $4.8 million for Roche Cobas 6800 SARS-CoV-2 testing kits to be delivered from May 2022 through April 2024. Two firm fixed price delivery orders were subsequently issued against the contract. The first, valued at $442,784,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VA-VHA VISN 2) awarded an Indefinite Delivery Contract to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostic products, to provide viral load testing services for the Bronx VA Medical Center Laboratory. The contract, with a potential value of $7,504,061.70, does not include any set-aside designations.
Through a series of firm fixed price delivery orders, Roche Diagnostics will perform viral load testing for HIV, hepatitis C, hepatitis B, and cytomegalovirus to support the clinical laboratory operations at the Bronx VA Medical Center in New York and Castleton, Indiana. The orders range in value from $348,343.92 to $1,910,316.40 and cover performance periods from October 2019 through September 2024. Roche Diagnostics will provide the necessary equipment, reagents, and personnel to conduct the testing, interfacing with the VA's VISTA medical information system. The contract aims to enhance diagnostic capabilities and support the VA's mission of providing quality healthcare to veterans.